Treatment of 1,3-C6H4I2 with Pt(PEt3)(4) in toluene leads to the isolation of [1,3-(Pt(PEt3)(2)I)(2)C6H4] (2). This complex has been characterized by H-1, C-13 and P-31 NMR and elemental analysis. The structure of 2 as well as that of [1,4-(Pt(PEt3)(2)I)(2)C6H4] (1) have been determined by single crystal X-ray analysis. As expected, the platinum centers of these derivatives adopt a square planar coordination geometry with the phosphine ligands in a trans arrangement. Treatment of compounds 1 and 2 with AgPF6 and subsequent addition of two equivalents of NITpPy (NITpPy = [2-(4-pyridyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide]) results in the formation of [1,4-(Pt(PEt3)(2)(NITpPy))(2)C6H4](2+)[PF6](-)(2) (3) and [1,3-(Pt(PEt3)(2)(NITpPy))(2)C6H4](2+)[PF6](-)(2) (4), respectively. Compounds 3 and 4 have been characterized by +ESI/TOF, IR, UV and elemental analysis. Their structures have been determined by X-ray crystallography which con firmed the coordination of a NITpPy ligand at each platinum center. As in 1 and 2, the platinum centers adopt a square planar coordination geometry with the phosphine ligands in a trans arrangement. As shown by EPR spectroscopy and SQUID magnetometry, intramolecular magnetic coupling of the coordinated NITpPy moieties does not occur.